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COVID-19 has had a devastating
impact on the care of cancer
patients. Thus, tele-oncology has
become a necessity to improve
cancer care. Several organisations
have issued guidelines for its use
during COVID-19. Despite certain
shortcomings, tele-oncology has
great potential to help cancer
patients during COVID-19 and in
the future.
Introduction
The coronavirus disease 2019 (COVID-19),
caused by the severe acute respiratory
syndrome virus (SARS-CoV-2), has re-
sulted in a pandemic that has placed
immense pressure on health care systems
around the world. This has resulted in
hospitals sending patients home if they
are not acutely unwell and do not require
urgent attention, further leading to an
increase in patients from specialties like
oncology not being able to attend hospitals
for non-urgent care. As a result, tele-
oncology has taken a more prominent role
in the COVID-19 pandemic.
Tele-oncology is defined as the delivery of
clinical oncology services via audio and
video communication technologies to
patients at a distance. It is effective in pro-
viding remote chemotherapy supervision,
symptom management, and palliative
care to cancer patients [1]. Telemedicine
and its applications in different specialties
such as cardiology, respiratory medicine,
and neurology has been extensively
researched and satisfactory outcomeshave been reported [2]. However, its
use in oncology, and in particular during
COVID-19, has not garnered the same
attention.
Transition to Tele-oncology
A growing trend of telemedicine in oncology
has been observed, with a call for outpatient
visits and triage to be shifted to phone
consultations, incorporating a risk–benefit
balance. This reduces the risk of contagion
for the health personnel and patients, espe-
cially when the potential benefit of an
oncological intervention in terms of cancer
recurrence/overall survival is so small that it
does not counterbalance the potential risk
of death from COVID-19 [3].
It is well established that comorbidities
and immunosuppression are common
risk factors for severity and mortality. As
cancer and cancer treatment frequently
cause immunosuppression, they increase
the susceptibility to contracting the virus.
In addition, hyperinflammatory response to
the infection may be responsible for organ
damage associated with severe COVID-19
in the immunocompromised [4]. Therefore,
major shifts in the clinical care of cancer
are currently underway, with more light
being shed on tele-oncology.
Several organizations have endorsed the
use of tele-oncology and issued guidelines
for its use during COVID-19. The European
Society for Medical Oncology (ESMO) rec-
ommends that patients undertaking oral
treatments should be transferred to tele-
phonic consultation and web-technology
contacts for a prescription renewal. ESMO
also endorses the use of telephone and
web-technology for toxicity evaluation,
dose adaptation, and supportive care
recommendation [5]. The tiered approach
of ESMO advises that low and medium
priority cancer patients be referred to tele-
oncology services as much as possible.
The National Health Service in England
has issued guidance to support theuse of telephone or video consultation
wherever possible to minimise face-to-
face appointments [3]. Additionally, if staff
have to self-isolate for any reason, they
could still continue to provide care and
support multidisciplinary teams (MDTs)
through video consultations and virtual
attendance at MDT meetings [1].
Many different types of technologies have
been adopted by tele-oncology to further
the health of cancer patients. These include
web conferencing, videoconferencing,
tele-synergy, and virtual tele-microscope.
The advantages and disadvantages of
the various technologies are summarised
in Table 1 [6].
Analysing 200 patient interactions, Lewis
et al. proved that great patient satisfac-
tion is associated with the radiation
oncology services provided virtually,
hence, concluding that tele-oncology is
an efficient and cost-effective method of
providing high-quality services for the
long-term follow-up of cancer patients
[7]. Tele-oncology can also be useful
to triage for COVID-19. A video-based
consultation would enable clinicians to
establish a history of symptoms, expo-
sure risk, and observational assessment.
This would aid the clinicians in making
the decision to test a particular individual
for COVID-19 [8].
Disadvantages of Telemedicine in
Oncology
It goes without saying that in the current
unprecedented times, tele-oncology is
a preferable option over in-person consul-
tations; however, tele-oncology has a
few shortcomings. The major drawbacks
include jurisdictional limitations of the
physicians’ practice, the need for training
on tele-oncology tools that may be limited
in a pandemic setting, and limitation of
physical exams. Moreover, robust guide-
lines on appropriate oncological surveil-
lance over the phone or video in different
subspecialties need to be issued [9].Trends in Cancer, Month 2020, Vol. xx, No. xx 1
Table 1. Summary of the Advantages and Disadvantages of Telehealth Technologies in Oncologya
Technology Advantages Disadvantages
Web conferencing • Low cost
• Wide availability
• Limited resolution of images
• Participants may not see each
other
Video conferencing • Good image resolution
• Participants can see each other
• Readily available
• Can present/interview patients
• Expensive
• Requires maintenance
Tele-synergy • A multimedia workstation integrates
all components for collaborative
multidisciplinary tele-oncology
• Transmits images from their primary
sources
• Allows image manipulation
• Supports comprehensive
multidisciplinary case review and
discussion
• Supports collaborative planning of
radiation and surgery
• Very expensive
• Requires ~20 ISDN channels
• Requires many peripheral
components
• Difficult to install
• Requires intensive maintenance
• Requires dedicated storage
space
Virtual tele-microscope • Operator can control microscope
without special hardware or software
• Limited to pathology
• Expensive
• Performance depends on the
user’s computer
aAdapted from Hazin and Qaddoumi [6].
Trends in CancerA systematic review analysing the
effectiveness of video consultations in
oncology concluded that clinical care
was not compromised with the use of
video conferences. Despite the overall
positive results of the study, patients
reported feelings of nervousness, diffi-
culty, or reluctance to communicate
with providers using television-based
systems. A feeling of emotional distance
between the patients and providers was
also observed [9].
Traditional tele-oncology cannot be ex-
tended to patients with impaired hearing,
vision, or cognition [9]. Also, linguistic dis-
parities must be taken into consideration
to avoid miscommunication and feelings
of anxiety when communicating with
people belonging to ethnic minority
groups. Therefore, the delivery of tele-
oncology has to be modified on a case-
by-case basis in such circumstances [10].
With regards to the COVID-19 pandemic,
implementation of tele-oncology can be
disruptive, especially when it is adopted2 Trends in Cancer, Month 2020, Vol. xx, No. xxquickly out of necessity. Moreover, a
cross-sectional analysis of population-
level interest and telehealth capacity of
US hospitals show that the interest
in telehealth increased as the number
of COVID-19 cases increased (r = 0.948,
P b 0.001). However, the population-level
interest failed to correlate with the propor-
tion of hospitals providing telehealth ser-
vices, further suggesting that increased
population demand may not be met with
the current telehealth capacity [11].
These results raise questions regarding
the preparedness and telecommunication
infrastructure of the hospitals extending
tele-oncology services to patients [11]. The
usage of tele-oncology is not new however,
COVID-19 has forced the widespread
adoption of these techniques, leading to
rapid adaptation to a newway of communi-
cation, which is preferred most of the time
but can be disruptive as well.
Concluding Remarks
Tele-oncology has an immense role to play
in the care of cancer patients during thispandemic. It has started to be widely
adopted by healthcare systems to reduce
the risk of a potentially fatal COVID-19 in-
fection in cancer patients. It is an excellent
tool for long-term follow-up of patients,
especially those in remote areas [7]. Tele-
oncology has also helped widen collabo-
rations across the world, in particular for
challenging cancer cases. Studying the
outcomes of patients that are currently re-
ceiving altered schedules for cancer care
will help detect patient cohorts that may
benefit from altered treatment protocols.
Data collected from the delivery of care
to cancer patients during COVID-19
will also help form caremodels and predic-
tors for high-risk populations in future
epidemics [12].1Department of Medicine, Queen’s University Belfast, School of
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